Note 2 – Liquidity and Management Plans

During the three and nine months ended September 30, 2018, the Company recorded revenue of $228,000 and $458,773, respectively, and during the three and nine months ended September 30, 2017, the Company recorded revenue of $250,000 and $1,124,874, respectively. During the three and nine months ended September 30, 2018, the Company recorded a net loss of $12,645,291 and $38,387,119, respectively. During the three and nine months ended September 30, 2017, the Company recorded a net loss of $12,748,248 and $38,140,398, respectively. Net cash used in operating activities was $24,398,264 and $26,887,004 for the nine months ended September 30, 2018 and 2017, respectively. The Company is currently meeting its liquidity requirements through an at-the-market (“ATM”) sale of common stock in January 2018, which raised net proceeds of $38,846,815, the sales of shares to a private investor during July 2017, which raised net proceeds of $14,932,547, and payments received under product development projects.

As of September 30, 2018, the Company had cash on hand of $28,551,870. The Company expects that cash on hand as of September 30, 2018, together with anticipated revenues, will be sufficient to fund the Company’s operations into the fourth quarter of 2019.

Research and development of new technologies is by its nature unpredictable. Although the Company will undertake development efforts with commercially reasonable diligence, there can be no assurance that its available resources, including the net proceeds from the Company’s financings to date, will be sufficient to enable it to develop and obtain regulatory approval of its technology to the extent needed to create future revenues sufficient to sustain its operations. The Company may pursue additional financing, which could include follow-on equity offerings, debt financing, co-development agreements or other alternatives, depending upon market conditions. Should the Company choose to pursue additional financing, there is no assurance that such financing would be available on terms that it would find acceptable, or at all.

The market for products using the Company’s technology is broad, but is nascent and unproven, so the Company’s success is sensitive to many factors, including technological feasibility, regulatory approval, customer acceptance, competition and global market fluctuations.